Correspondence 0001493152-23-043346 from Microbot Medical Inc. (MBOT)

Microbot Medical Inc.
Date: Dec. 1, 2023 · CIK: 0000883975 · Accession: 0001493152-23-043346

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275634

Date

Dec. 1, 2023

Author

Microbot

Form

CORRESP

Company

Microbot Medical Inc.

Letter

Microbot Medical Inc.

Grove Street, Suite 388

Braintree, MA 02184

December 1, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F. St., N.E.

Washington, D.C. 20549

Re: Request for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No. 333-275634)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Microbot Medical Inc. hereby requests the acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-275634) so that it will become effective on Monday, December 4, 2023 at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.

Very
truly yours,
Microbot
Medical Inc.

Show Raw Text

CORRESP
1
filename1.htm

Microbot
Medical Inc.

288
Grove Street, Suite 388

Braintree,
MA 02184

December
1, 2023

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F. St., N.E.

Washington,
D.C. 20549

    Re:
    Request
    for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No. 333-275634)

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Microbot Medical Inc. hereby requests the acceleration of the effective date
of the above-referenced Registration Statement on Form S-3 (File No. 333-275634) so that it will become effective on Monday, December
4, 2023 at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.

    Very
    truly yours,

    Microbot
    Medical Inc.

    By:
    /s/
    Harel Gadot

    Name:
    Harel
    Gadot

    Title:
    CEO,
    President and Chairman

SecProbe.io